Your session is about to expire
← Back to Search
Quality Improvement Care Bundles for Premature Birth (ABC-QI Trial)
ABC-QI Trial Summary
This trial is testing whether using quality improvement methods and care bundles will decrease the hospital stay for premature babies.
ABC-QI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowABC-QI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ABC-QI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My baby was born early and has a major birth defect or genetic issue.My baby was born between 32 and 36 weeks and is in the NICU or postpartum unit.
- Group 1: Control Arm- Current management
- Group 2: Intervention Arm- Collaborative Quality implementation Strategies
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who is able to qualify as a participant of this experiment?
"The requirements for joining this clinical trial include a length of stay and being between 32 Weeks to 36 Weeks old. This particular study requires 9500 individuals in total."
Does the candidacy for this medical trial extend to those who are older than seventy-five?
"This trial has a specific age range requirement; patients must be between 32-36 weeks old. Meanwhile, there are 185 clinical trials available for individuals under 18 years of age and 77 more appropriate for those over 65."
Is there still an opportunity to enroll in this research endeavor?
"As indicated on clinicaltrials.gov, this medical investigation is no longer looking for participants due to its last update occurring on September 19th of 2022; however, there are currently 264 other trials open and recruiting patients."
Share this study with friends
Copy Link
Messenger